Rigel Pharmaceuticals | Betriebsergebnis





Betriebsergebnis Veränderung Datum
Agenus USD -13.31M 12.58M 2025-03
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 32.1M 2025-03
Arrowhead Research USD 40.81M 3.3M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celldex Therapeutics USD -73.62M 9.76M 2025-09
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Halozyme Therapeutics USD 217.92M 15.48M 2025-09
Heron Therapeutics USD -5.66M 782K 2024-09
Intrexon USD -60.84M 26.62M 2024-06
Ionis Pharmaceuticals USD -160.18M 300.02M 2025-09
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
MacroGenics USD 18.64M 55.4M 2025-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Veracyte USD 23.11M 8.8M 2025-09


Rigel Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.